title: Can intermediate monocytes predict response to infliximab therapy in sarcoidosis?
authors.affiliation: Interstitial Lung Diseases Centre of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands Dept of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, The Netherlands Both authors contributed equally.
authors.forename: Daniëlle
authors.initials: D
authors.lastname: Hijdra
authors.affiliation: Interstitial Lung Diseases Centre of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands Both authors contributed equally a.vorselaars@antoniusziekenhuis.nl.
authors.forename: Adriane D M
authors.initials: AD
authors.lastname: Vorselaars
authors.affiliation: Interstitial Lung Diseases Centre of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands Dept of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands.
authors.forename: Heleen A
authors.initials: HA
authors.lastname: Crommelin
authors.affiliation: Interstitial Lung Diseases Centre of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands Division of Heart & Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands.
authors.forename: Coline H M
authors.initials: CH
authors.lastname: van Moorsel
authors.affiliation: Dept of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, The Netherlands.
authors.forename: Bob
authors.initials: B
authors.lastname: Meek
authors.affiliation: Dept of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, The Netherlands.
authors.forename: Anke M E
authors.initials: AM
authors.lastname: Claessen
authors.affiliation: Dept of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, The Netherlands Dept of Sciences, Roosevelt Academy, Middelburg, The Netherlands.
authors.forename: Ger T
authors.initials: GT
authors.lastname: Rijkers
authors.affiliation: Interstitial Lung Diseases Centre of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands Division of Heart & Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands.
authors.forename: Jan C
authors.initials: JC
authors.lastname: Grutters
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D016022:Case-Control Studies; D019788:Fluorodeoxyglucose F18; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use*; D007958:Leukocyte Count; D009000:Monocytes / Q000276:immunology* / Q000378:metabolism; D049268:Positron-Emission Tomography; D011379:Prognosis; D019275:Radiopharmaceuticals; D017452:Receptors, IgG / Q000378:metabolism; D012507:Sarcoidosis / Q000188:drug therapy* / Q000276:immunology
chemical_list: D018501:Antirheumatic Agents; D019275:Radiopharmaceuticals; D017452:Receptors, IgG; D019788:Fluorodeoxyglucose F18; D000069285:Infliximab